Skip to main content

Advertisement

Log in

Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy

  • CLINICAL INVESTIGATION
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To determine the efficacy of photodynamic therapy (PDT) with verteporfin for polypoidal choroidal vasculopathy (PCV).

Methods

PDT was performed in 35 patients (35 eyes) with PCV. We evaluated the number of treatments and compared visual acuity (VA), ophthalmological findings, and changes in polypoidal lesions and branching vascular networks by measuring lesion diameters using Heidelberg retina angiography before PDT, and then every 3 months for 1 year after PDT.

Results

The mean annual number of treatment sessions was 2.2. VA was improved or maintained in 80% of the patients. Retinal pigment epithelium detachment, retinal detachment, hemorrhage, and/or exudates disappeared in 69%, and leakage resolved in 74% of the patients. Polypoidal lesions disappeared completely on indocyanine green angiography in 83% of the patients. All branching vascular networks persisted. Polypoidal lesions had recurred at the termini of the remaining branching vascular networks at 9 months after the first PDT in two eyes and at 12 months in one eye.

Conclusions

PDT with verteporfin for PCV appears to improve or maintain VA for the first posttreatment year. Approximately 70% of PCV cases showed improved ophthalmoscopic findings. However, as polypoidal lesions recur after PDT in some cases, further study is needed to confirm the long-term efficacy of PDT for PCV. Jpn J Ophthalmol 2007;51:270–277 @ Japanese Ophthalmological Society 2007

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. LA Yannuzzi J Sorenson RF Spaide et al. (1990) ArticleTitleIdiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1–8 Occurrence Handle1693009 Occurrence Handle10.1097/00006982-199001010-00001 Occurrence Handle1:STN:280:By%2BB28%2FjvF0%3D

    Article  PubMed  CAS  Google Scholar 

  2. RF Spaide LA Yannuzzi JS Slakter et al. (1995) ArticleTitleIndocyanine green video angiography of idiopathic polypoidal vasculopathy Retina 15 100–110 Occurrence Handle7542796 Occurrence Handle10.1097/00006982-199515020-00003 Occurrence Handle1:STN:280:ByqA2M%2FksFU%3D

    Article  PubMed  CAS  Google Scholar 

  3. SC Lee YS Seong SS Kim et al. (2004) ArticleTitlePhotodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula Ophthalmologica 218 193–201 Occurrence Handle15103216 Occurrence Handle10.1159/000076844 Occurrence Handle1:CAS:528:DC%2BD2cXjt12rs7k%3D

    Article  PubMed  CAS  Google Scholar 

  4. WM Chan DS Lam TY Lai et al. (2004) ArticleTitlePhotodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576–1584 Occurrence Handle15288991 Occurrence Handle10.1016/j.ophtha.2003.12.056

    Article  PubMed  Google Scholar 

  5. N Hussain A Hussain S Natarajan (2005) ArticleTitleRole of photodynamic therapy in polypoidal choroidal vasculopathy Indian J Ophthalmol 53 101–104 Occurrence Handle15976464

    PubMed  Google Scholar 

  6. RM Silva J Figueira ML Cachulo et al. (2005) ArticleTitlePolypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 973–979 Occurrence Handle15864616 Occurrence Handle10.1007/s00417-005-1139-4 Occurrence Handle1:CAS:528:DC%2BD2MXhtFart7fN

    Article  PubMed  CAS  Google Scholar 

  7. InstitutionalAuthorNameJapanese Study Group of Polypoidal Choroidal Vasculopathy (2005) ArticleTitleCriteria for diagnosis of polypoidal choroidal vasculopathy (in Japanese with English abstract) Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 109 417–427

    Google Scholar 

  8. K Sho K Takahashi H Yamada et al. (2003) ArticleTitlePolypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392–1396 Occurrence Handle14557174 Occurrence Handle10.1001/archopht.121.10.1392

    Article  PubMed  Google Scholar 

  9. W-M Chan TYY Lai Y Tano DTL Liu KKW Li DSC Lam (2006) ArticleTitlePhotodynamic therapy in macular diseases of Asian populations: when East meets West Jpn J Ophthalmol 50 161–169 Occurrence Handle16604394 Occurrence Handle10.1007/s10384-005-0259-z Occurrence Handle1:CAS:528:DC%2BD28XktFaqsro%3D

    Article  PubMed  CAS  Google Scholar 

  10. BJ Rosenblatt GK Shah K Blinder (2005) ArticleTitlePhotodynamic therapy with verteporfin for peripapillary choroidal neovascularization Retina 25 33–37 Occurrence Handle15655438 Occurrence Handle10.1097/00006982-200501000-00004

    Article  PubMed  Google Scholar 

  11. U Schlotzer-Schrehardt A Viestenz GO Naumann et al. (2002) ArticleTitleDose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 748–757 Occurrence Handle12271373

    PubMed  Google Scholar 

  12. M Yuzawa R Mori M Haruyama (2003) ArticleTitleA study of laser photocoagulation for polypoidal choroidal vasculopathy Jpn J Ophthalmol 47 379–384 Occurrence Handle12842207 Occurrence Handle10.1016/S0021-5155(03)00042-X

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eriko Akaza.

About this article

Cite this article

Akaza, E., Yuzawa, M., Matsumoto, Y. et al. Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy. Jpn J Ophthalmol 51, 270–277 (2007). https://doi.org/10.1007/s10384-007-0452-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-007-0452-3

Key words

Navigation